Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft. Learn more about your ad choices. Visit megaphone.fm/adchoices

Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="noopener noreferrer">megaphone.fm/adchoices</a>

46: Biotech's Big Idea

The Readback explores why only a few of our most hyped companies and ideas end up meeting their promise. The lessons learned hold value not just for investors, but for everyone trying to find the next big thing.

Share 46: Biotech's Big Idea

Sign up to save your podcasts

46: Biotech's Big Idea

46: Biotech's Big Idea

More shows like The Readback

Numbers by Barron's

Barron's Streetwise

Barron's Advisor

Barron's Live

At Barron's